Xu, Yongfang
Xiong, Mengqi
Chen, Wei
Yao, Chengjie
Chen, Yunhao
Man, Da
Xie, Haiyang
Ye, Xiujin
Jia, Changku
Funding for this research was provided by:
Zhejiang Provincial Natural Science Foundation of China (LZ22H080002)
Medicine and Health Science and Technology Plan Projects of Zhejiang Province (2022KY245)
Research Unit Project of Chinese Academy of Medical Sciences (2019-I2M-5-030)
Article History
Received: 25 January 2025
Accepted: 6 February 2026
First Online: 7 March 2026
Declarations
:
: The authors declare no competing interests.
: We complied with all relevant ethical regulations for working with patient resources and experimental animals (reference number:2021 − 1380). The animal experiments were carried out in compliance with the ARRIVE guidelines. The clinical study was approved by the Institutional Review Board at The First Affiliated Hospital, Zhejiang University School of Medicine (reference number:2019 − 1421) and Affiliated Hangzhou First People’s Hospital (reference number:2021 − 302). Informed consent was obtained from all the patients.